Symptomtext
on 28jun2023 patient received a dose on menquadfi, then on 28jul2023, patient received another dose of menquadfi with no reported adverse event; Initial information was received on 01-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 years old female patient who received meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi] on 28-Jun-2023, then on 28-Jul-2023, patient received another dose of menquadfi with no reported adverse event. The patient's past vaccination(s) included Menquadfi in 2018. The patient's past medical history, medical treatment(s) and family history were not provided. On 28-Jun-2023 the patient received a dose of meningococcal a-c-y-w135 (t conj) vaccine Solution for injection at dose of 0.5 ml (strength: standard, frequency: 2, lot number: U7595AA, expiration date: 11-Mar-2025) via intramuscular route in the right deltoid for Immunization (immunisation) and on 28-Jul-2023, the patient received a dose of same vaccine at dose of 0.5 ml (strength: standard, lot U7643AA, expiration date: 27-Jun-2025) via intramuscular route in the right deltoid for Immunization (immunisation) with no reported adverse event (inappropriate schedule of product administration) (latency: same day). No lab data reported. Action taken: was not applicable. At time of reporting, the outcome was Unknown for the event on 28jun2023 patient received a dose on menquadfi, then on 28jul2023, patient received another dose of menquadfi with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.